Roth MKM analyst Eric Handler keeps a Buy rating and $26 price target on Imax, stating that despite the lower projected Q2 box office, the stock remains the preferred way to play the global box office recovery. Blockbuster movies are generally performing well across IMAX’s network, the company’s market share remains elevated, and the Chinese box office is seeing a particularly strong recovery, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on IMAX:
- IMAX Plans Full Acquisition of Chinese Subsidiary, Set for Expansion
- IMAX Corporation Announces Intent to Acquire Full Ownership of IMAX China Subsidiary
- Domestic Q2 box office revenues topped estimate, says B. Riley
- Imax, Beach House, China Review Studio join forces on documentary
- B. Riley reiterates Buys on Imax, Marcus despite two recent ‘duds’